UBS Group’s EUDA Health Holdings EUDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-36
| Closed | -$1.67K | – | 10676 |
|
|
2025
Q4 | $1.67K | Buy |
36
+34
| +1,700% | +$1.82K | ﹤0.01% | 9501 |
|
|
2025
Q3 | $83 | Sell |
2
-228
| -99% | -$11.1K | ﹤0.01% | 9953 |
|
|
2025
Q2 | $16.5K | Sell |
230
-748
| -76% | -$55.5K | ﹤0.01% | 8570 |
|
|
2025
Q1 | $71.2K | Sell |
978
-1,163
| -54% | -$91.2K | ﹤0.01% | 7313 |
|
|
2024
Q4 | $192K | Buy |
2,141
+1,958
| +1,070% | +$173K | ﹤0.01% | 6476 |
|
|
2024
Q3 | $14.1K | Sell |
183
-348
| -66% | -$27.5K | ﹤0.01% | 7554 |
|
|
2024
Q2 | $32.6K | Buy |
531
+526
| +10,520% | +$23.6K | ﹤0.01% | 7007 |
|
|
2024
Q1 | $162 | Buy |
+5
| New | +$149 | ﹤0.01% | 8766 |
|
|
2023
Q2 | – | Sell |
-137
| Closed | -$4.11K | – | 9101 |
|
|
2023
Q1 | $4.11K | Buy |
137
+67
| +96% | +$2.27K | ﹤0.01% | 8231 |
|
|
2022
Q4 | $2.32K | Buy |
70
+7
| +11% | +$818 | ﹤0.01% | 9698 |
|
|
2022
Q3 | $13K | Buy |
63
+10
| +19% | +$1.99K | ﹤0.01% | 8021 |
|
|
2022
Q2 | $10K | Buy |
53
+50
| +1,667% | +$9.86K | ﹤0.01% | 7956 |
|
|
2022
Q1 | $0 | Buy |
+3
| New | +$587 | ﹤0.01% | 10416 |
|
UBS Group's EUDA Position: Q1 2026 in Review
UBS Group sold out of EUDA Health Holdings (EUDA) in Q1 2026, closing a stake of 36 shares — an estimated $1.67K sold.
UBS Group first reported a position in EUDA in Q1 2022 and held it in 13 quarters. The position peaked at $192K in Q4 2024. 0 funds tracked by Wall St. Rank hold EUDA as of Q1 2026.
- UBS Group reported no remaining EUDA Health Holdings position as of Q1 2026 after selling out during the quarter.
- UBS Group sold 36 EUDA Health Holdings shares in Q1 2026, an estimated $1.67K.
- UBS Group first reported a position in EUDA Health Holdings in Q1 2022 and held it in 13 quarters.
- UBS Group's EUDA Health Holdings position peaked at $192K in Q4 2024.
- 0 funds tracked by Wall St. Rank held EUDA Health Holdings as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.